Fernando Benitez
Tell me more about Fernando Benitez?
Fernando Benitez is an experienced professional who has worked at Novartis in Switzerland-Basel-stadt-Basel. He holds the position of N in the Other department. Novartis, founded in 1996, is a leading pharmaceutical manufacturing company with over 10,001 employees. They specialize in producing medicines, therapies, vaccines, diagnostics, and diagnostics. Their target customers include patients, healthcare professionals, hospitals, and government agencies. Fernando Benitez's expertise lies in the field of pharmaceutical manufacturing, specifically in the areas of medicine, therapies, vaccines, diagnostics, and medical devices.
For inquiries about Phone Number and Email, please click here Unlock Contact
Emails and Phone Numbers
Work Experience
N
Pharmaceutical Manufacturing
Fernando Benitez's Professional Milestones
- N: Building a high-performing team through exceptional leadership and effective leadership.
Certification
Colleagues
Thomas Loe
Executive Cardiovascular Sales Representative II at Novartis, Owner at Isotope Shielding Technologies, LLC
Alexander Iliyashov
Finance Professional | Master Digital Transformation | Business Analyst | Data Scientist | Data & Machine Learning Engineer | Cloud Architect | Project Manager | Quick Start Engineer | Job
Žiga Kopinšek
global artwork process owner innovative medicines & safety label change & project orbit artwork lead
SUNNY Chawla
Business Owner
Sonia Espejo Rivas
customer experience | customer engagement | digital transformation | product owner | product manager | data digital & technology |
Other Named Fernando Benitez
Frequently asked questions
We found 1 Fernando Benitez's email addresses
Fernando Benitez's social media include: Linkedin,
Fernando Benitez works for Novartis
Fernando Benitez's role in Novartis is N
Fernando Benitez works in the industry of Pharmaceutical Manufacturing
Fernando Benitez's colleagues are Thomas Loe,Alexander Iliyashov,Žiga Kopinšek
Fernando Benitez's latest job experience is N at Novartis